Table 1 Clinicopathologic characteristics of patients with localized renal cell carcinoma.

From: Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma

Number of patient

  

42

Age, yr, median (range)

  

64 (40–80)

Female/Male, n

  

9/33

Tumor size, cm, mean ± SD

  

5.7 ± 2.6

Histology, n (%)

Clear cell

 

37 (88.1)

 

Non-clear

Papillary

2 (4.8)

  

Chromophobe

1 (2.4)

  

Chromophobe & collecting duct

1 (2.4)

  

Neuroendocrine

1 (2.4)

 

lyv ( +)

 

22 (52.4)

pT stage, n (%)

1a

 

13 (31.0)

 

1b

 

7 (16.7)

 

2a

 

3 (7.1)

 

2b

 

1 (2.4)

 

3a

 

11 (26.2)

 

3b

 

4 (9.5)

 

4

 

3 (7.1)